BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spradling PR, Rupp L, Moorman AC, Lu M, Teshale EH, Gordon SC, Nakasato C, Boscarino JA, Henkle EM, Nerenz DR, Denniston MM, Holmberg SD; Chronic Hepatitis Cohort Study Investigators. Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clin Infect Dis 2012;55:1047-55. [PMID: 22875876 DOI: 10.1093/cid/cis616] [Cited by in Crossref: 123] [Cited by in F6Publishing: 123] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Jakobsen JC, Nielsen EE, Feinberg J, Fobian K, Katakam KK, Hauser G, Poropat G, Djurisic S, Weiss KH, Bjelakovic M, Bjelakovic G, Klingenberg SL, Liu JP, Nikolova D, Koretz RL, Gluud C, Jakobsen JC. Direct-acting antivirals for chronic hepatitis C. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd012143] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Ward JW. Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention. Ann Intern Med. 2012;157:817-822. [PMID: 22910836 DOI: 10.7326/0003-4819-157-9-201211060-00529] [Cited by in Crossref: 216] [Cited by in F6Publishing: 188] [Article Influence: 24.0] [Reference Citation Analysis]
3 Gerbi GB, Rupp LB, Ko SC, Moorman AC, Holmberg SD, Xu F; the CHeCS Investigators. Reported reasons for testing among hepatitis B virus-infected patients - Chronic Hepatitis Cohort Study (CHeCS), United States, 2006-2010. Liver Int 2014;34:e162-3. [DOI: 10.1111/liv.12509] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
4 Shah HA, Heathcote J, Feld JJ. A Canadian screening program for hepatitis C: is now the time? CMAJ 2013;185:1325-8. [PMID: 24082023 DOI: 10.1503/cmaj.121872] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
5 Mahajan R, Xing J, Liu SJ, Ly KN, Moorman AC, Rupp L, Xu F, Holmberg SD; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010. Clin Infect Dis. 2014;58:1055-1061. [PMID: 24523214 DOI: 10.1093/cid/ciu077] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 10.8] [Reference Citation Analysis]
6 Abara WE, Moorman AC, Zhong Y, Collier MG, Rupp LB, Gordon SC, Boscarino JA, Schmidt MA, Trinacty CM, Holmberg SD, for the Checs Investigators. The Predictive Value of International Classification of Disease Codes for Chronic Hepatitis C Virus Infection Surveillance: The Utility and Limitations of Electronic Health Records. Population Health Management 2018;21:110-5. [DOI: 10.1089/pop.2017.0004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
7 Kennedy PTF, Litwin S, Dolman GE, Bertoletti A, Mason WS. Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks. Viruses 2017;9:E96. [PMID: 28468285 DOI: 10.3390/v9050096] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
8 Suryaprasad A, Byrd KK, Redd JT, Perdue DG, Manos MM, McMahon BJ. Mortality caused by chronic liver disease among American Indians and Alaska Natives in the United States, 1999-2009. Am J Public Health 2014;104 Suppl 3:S350-8. [PMID: 24754616 DOI: 10.2105/AJPH.2013.301645] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
9 Larney S, Mahowald MK, Scharff N, Flanigan TP, Beckwith CG, Zaller ND. Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings. Am J Public Health 2014;104:e69-74. [PMID: 24825235 DOI: 10.2105/AJPH.2014.301943] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
10 Trager E, Khalili M, Masson CL, Vittinghoff E, Creasman J, Mangurian C. Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers. Am J Public Health 2016;106:740-2. [PMID: 26890183 DOI: 10.2105/AJPH.2016.303059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Sam SS, Steinmetz HB, Tsongalis GJ, Tafe LJ, Lefferts JA. Validation of a solid-phase electrochemical array for genotyping hepatitis C virus. Exp Mol Pathol. 2013;95:18-22. [PMID: 23583628 DOI: 10.1016/j.yexmp.2013.04.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
12 Kanwal F, Lok AS, El-Serag HB. CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. Clin Gastroenterol Hepatol 2013;11:200-3. [PMID: 23432900 DOI: 10.1016/j.cgh.2013.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
13 Mahajan R, Liu SJ, Klevens RM, Holmberg SD. Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010. Am J Public Health 2013;103:1445-9. [PMID: 23763404 DOI: 10.2105/AJPH.2013.301211] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
14 Raines-Milenkov A, Felini M, Baker E, Acharya R, Longanga Diese E, Akpan I, Hussain A, Wagner T. Hepatitis B Virus Awareness, Infection, and Screening Multiethnic Community Intervention for Foreign-Born Populations. J Community Health 2021. [PMID: 33772683 DOI: 10.1007/s10900-021-00982-5] [Reference Citation Analysis]
15 Backus LI, Belperio PS, Loomis TP, Mole LA. Impact of race/ethnicity and gender on HCV screening and prevalence among U.S. veterans in Department of Veterans Affairs Care. Am J Public Health 2014;104 Suppl 4:S555-61. [PMID: 25100421 DOI: 10.2105/AJPH.2014.302090] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
16 Hall EW, Rosenberg ES, Sullivan PS. Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010. BMC Infect Dis 2018;18:224. [PMID: 29769036 DOI: 10.1186/s12879-018-3133-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
17 Ford MM, Jordan AE, Johnson N, Rude E, Laraque F, Varma JK, Hagan H. Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations. J Public Health Manag Pract 2018;24:41-8. [PMID: 28141668 DOI: 10.1097/PHH.0000000000000519] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 Giannitrapani L, Soresi M, Balasus D, Licata A, Montalto G. Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. World J Gastroenterol 2013; 19(16): 2449-2455 [PMID: 23674845 DOI: 10.3748/wjg.v19.i16.2449] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
19 Yeboah-Korang A, Beig MI, Khan MQ, Goldstein JL, Macapinlac DM, Maurer D, Sonnenberg A, Fimmel CJ. Hepatitis C Screening in Commercially Insured U.S. Birth-cohort Patients: Factors Associated with Testing and Effect of an EMR-based Screening Alert. J Transl Int Med 2018;6:82-9. [PMID: 29984203 DOI: 10.2478/jtim-2018-0012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
20 García-Alonso FJ, Bonillo-Cambrodón D, Bermejo A, García-Martínez J, Hernández-Tejero M, Valer López Fando P, Piqueras B, Bermejo F. Acceptance, yield and feasibility of attaching HCV birth cohort screening to colorectal cancer screening in Spain. Dig Liver Dis 2016;48:1237-42. [PMID: 27481585 DOI: 10.1016/j.dld.2016.06.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Patel RC, Vellozzi C, Smith BD. Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014. Public Health Rep 2016;131 Suppl 2:12-9. [PMID: 27168656 DOI: 10.1177/00333549161310S203] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 5.6] [Reference Citation Analysis]
22 Spradling PR, Xing J, Rupp LB, Moorman AC, Gordon SC, Lu M, Teshale EH, Boscarino JA, Schmidt MA, Daida YG, Holmberg SD. Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017. Journal of Clinical Gastroenterology 2021;55:77-83. [DOI: 10.1097/mcg.0000000000001344] [Reference Citation Analysis]
23 Jewett A, Garg A, Meyer K, Wagner LD, Krauskopf K, Brown KA, Pan JJ, Massoud O, Smith BD, Rein DB. Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings. Health Promot Pract 2015;16:256-63. [PMID: 24776636 DOI: 10.1177/1524839914532291] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
24 Boscarino JA, Sitarik A, Gordon SC, Rupp LB, Nerenz DR, Vijayadeva V, Schmidt MA, Henkle E, Lu M. Risk Factors for Hepatitis C Infection Among Vietnam Era Veterans Versus Nonveterans: Results from the Chronic Hepatitis Cohort Study (CHeCS). J Community Health 2014;39:914-21. [DOI: 10.1007/s10900-014-9863-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
25 Kiefer EM, Shi Q, Hoover DR, Kaplan R, Tracy R, Augenbraun M, Liu C, Nowicki M, Tien PC, Cohen M, Golub ET, Anastos K. Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS). J Acquir Immune Defic Syndr 2013;62:301-10. [PMID: 23221984 DOI: 10.1097/QAI.0b013e31827fdd61] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
26 Poonsapaya JM, Einodshofer M, Kirkham HS, Glover P, DuChane J. New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison. Cost Eff Resour Alloc 2015;13:17. [PMID: 26445564 DOI: 10.1186/s12962-015-0043-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
27 Xu F, Leidner AJ, Tong X, Holmberg SD. Estimating the Number of Patients Infected With Chronic HCV in the United States Who Meet Highest or High-Priority Treatment Criteria. Am J Public Health 2015;105:1285-9. [PMID: 25973816 DOI: 10.2105/AJPH.2015.302652] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
28 Yarbrough ML, Burnham CA. The ABCs of STIs: An Update on Sexually Transmitted Infections. Clin Chem 2016;62:811-23. [PMID: 27076632 DOI: 10.1373/clinchem.2015.240234] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
29 Isenhour CJ, Hariri SH, Hales CM, Vellozzi CJ. Hepatitis C Antibody Testing in a Commercially Insured Population, 2005-2014. Am J Prev Med 2017;52:625-31. [PMID: 28161033 DOI: 10.1016/j.amepre.2016.12.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
30 Galbraith JW, Donnelly JP, Franco RA, Overton ET, Rodgers JB, Wang HE. National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States. Clin Infect Dis 2014;59:755-64. [PMID: 24917659 DOI: 10.1093/cid/ciu427] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
31 Boscarino JA, Lu M, Moorman AC, Gordon SC, Rupp LB, Spradling PR, Teshale EH, Schmidt MA, Vijayadeva V, Holmberg SD; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS). Hepatology 2015;61:802-11. [PMID: 25203533 DOI: 10.1002/hep.27422] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
32 Lee S, Zhai S, Zhang GY, Ma XS, Lu X, Tan Y, Siu P, Seals B, Ma GX. Factors Associated with Hepatitis C Knowledge Before and After an Educational Intervention among Vietnamese Americans. Clin Med Insights Gastroenterol 2015;8:45-53. [PMID: 26561280 DOI: 10.4137/CGast.S24737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
33 Margusino-Framiñán L, Bobadilla-Pérez E, Cid-Silva P, Rodríguez-Sotelo A, Yáñez-Rubal JC, Mena-de-Cea Á, Suárez-López F, Prieto-Pérez A, Giménez-Arufe V, Delgado-Blanco M, Sanclaudio-Luhia AI, Martín-Herranz I, Castro-Iglesias Á. Effectiveness and safety of direct-acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice. J Med Virol 2020. [PMID: 32181917 DOI: 10.1002/jmv.25772] [Reference Citation Analysis]
34 Sarpel D, Baichoo E, Dieterich DT. Chronic hepatitis B and C infection in the United States: a review of current guidelines, disease burden and cost effectiveness of screening. Expert Review of Anti-infective Therapy 2016;14:511-21. [DOI: 10.1586/14787210.2016.1174066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
35 Bielen R, Kremer C, Koc ÖM, Busschots D, Hendrickx DM, Vanelderen P, Hens N, Nevens F, Robaeys G. Screening for hepatitis C at the emergency department: Should babyboomers also be screened in Belgium? Liver Int 2019;39:667-75. [PMID: 30525269 DOI: 10.1111/liv.14016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
36 Klok S, van Dulm E, Boyd A, Generaal E, Eskander S, Joore IK, van Cleef B, Siedenburg E, Bruisten S, van Duijnhoven Y, Tramper-Stranders G, Prins M. Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) infections among undocumented migrants and uninsured legal residents in the Netherlands: A cross-sectional study, 2018-2019. PLoS One 2021;16:e0258932. [PMID: 34714867 DOI: 10.1371/journal.pone.0258932] [Reference Citation Analysis]
37 Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, Kim JH, Lai CL, Lee HC, Lim SG, Liu CJ, Locarnini S, Al Mahtab M, Mohamed R, Omata M, Park J, Piratvisuth T, Sharma BC, Sollano J, Wang FS, Wei L, Yuen MF, Zheng SS, Kao JH. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1-98. [PMID: 26563120 DOI: 10.1007/s12072-015-9675-4] [Cited by in Crossref: 1076] [Cited by in F6Publishing: 1014] [Article Influence: 153.7] [Reference Citation Analysis]
38 Ford MM, Desai PS, Maduro G, Laraque F. Neighborhood Inequalities in Hepatitis C Mortality: Spatial and Temporal Patterns and Associated Factors. J Urban Health 2017;94:746-55. [PMID: 28623451 DOI: 10.1007/s11524-017-0174-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
39 Spradling PR, Tong X, Rupp LB, Moorman AC, Lu M, Teshale EH, Gordon SC, Vijayadeva V, Boscarino JA, Schmidt MA, Holmberg SD; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010. Clin Infect Dis 2014;59:976-81. [PMID: 24991025 DOI: 10.1093/cid/ciu509] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
40 Ward JW. The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States. Clin Liver Dis. 2013;17:1-11. [PMID: 23177279 DOI: 10.1016/j.cld.2012.09.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
41 Holmberg SD, Lu M, Rupp LB, Lamerato LE, Moorman AC, Vijayadeva V, Boscarino JA, Henkle EM, Gordon SC. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis. 2013;57:240-246. [PMID: 23592832 DOI: 10.1093/cid/cit245] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 9.9] [Reference Citation Analysis]
42 Castrejón M, Chew KW, Javanbakht M, Humphries R, Saab S, Klausner JD. Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers. Open Forum Infect Dis 2017;4:ofx109. [PMID: 28752101 DOI: 10.1093/ofid/ofx109] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
43 Valdiserri R, Khalsa J, Dan C, Holmberg S, Zibbell J, Holtzman D, Lubran R, Compton W. Confronting the emerging epidemic of HCV infection among young injection drug users. Am J Public Health 2014;104:816-21. [PMID: 24625174 DOI: 10.2105/AJPH.2013.301812] [Cited by in Crossref: 65] [Cited by in F6Publishing: 36] [Article Influence: 8.1] [Reference Citation Analysis]
44 Liu G, Holmberg SD, Kamili S, Xu F. Racial disparities in the proportion of current, unresolved hepatitis C virus infections in the United States, 2003-2010. Dig Dis Sci 2014;59:1950-7. [PMID: 24573716 DOI: 10.1007/s10620-014-3059-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
45 Younossi ZM, Stepanova M, Chan HLY, Lee MH, Yu ML, Dan YY, Choi MS, Henry L. Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir. Medicine (Baltimore) 2016;95:e2702. [PMID: 26945356 DOI: 10.1097/MD.0000000000002702] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 5.2] [Reference Citation Analysis]
46 Kuncio DE, Newbern EC, Fernandez-Viña MH, Herdman B, Johnson CC, Viner KM. Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system. J Urban Health 2015;92:379-86. [PMID: 25795212 DOI: 10.1007/s11524-015-9945-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
47 Beckwith CG, Kurth AE, Bazerman L, Solomon L, Patry E, Rich JD, Kuo I. Survey of US Correctional Institutions for Routine HCV Testing. Am J Public Health 2015;105:68-71. [PMID: 25393180 DOI: 10.2105/AJPH.2014.302071] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
48 Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, Holmberg SD. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160:293-300. [PMID: 24737271 DOI: 10.7326/m13-1133] [Cited by in Crossref: 492] [Cited by in F6Publishing: 264] [Article Influence: 61.5] [Reference Citation Analysis]
49 Gordon SC, Lamerato LE, Rupp LB, Li J, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Vijayadeva V, Boscarino JA, Henkle EM, Oja-Tebbe N, Lu M; CHeCS Investigators. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population. Clin Gastroenterol Hepatol 2014;12:885-93. [PMID: 24107395 DOI: 10.1016/j.cgh.2013.09.062] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 10.0] [Reference Citation Analysis]
50 Zuure F, Bil J, Visser M, Snijder M, Boyd A, Blom P, Sonder G, Schinkel J, Prins M. Hepatitis B and C screening needs among different ethnic groups: A population-based study in Amsterdam, the Netherlands. JHEP Rep 2019;1:71-80. [PMID: 32039354 DOI: 10.1016/j.jhepr.2019.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 King H, Soh JE, Thompson WW, Brown JR, Rapposelli K, Vellozzi C. Testing for Hepatitis C Virus Infection Among Adults Aged ≥18 in the United States, 2013-2017. Public Health Rep 2021;:333549211047236. [PMID: 34606398 DOI: 10.1177/00333549211047236] [Reference Citation Analysis]
52 Sun YT, Zhang YX, Tang H, Mao Q, Wang XZ, Zhang LY, Chen H, Zhong YN, Lin SM, Zhang DZ. Clinical characteristics and current management of hepatitis B and C in China. World J Gastroenterol 2014; 20(37): 13582-13590 [PMID: 25309089 DOI: 10.3748/wjg.v20.i37.13582] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
53 Xu F, Tong X, Leidner AJ. Hospitalizations And Costs Associated With Hepatitis C And Advanced Liver Disease Continue To Increase. Health Affairs 2014;33:1728-35. [DOI: 10.1377/hlthaff.2014.0096] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
54 Kanwal F, Lok AS, El-Serag HB. CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. Gastroenterology 2013;144:478-81. [PMID: 23419454 DOI: 10.1053/j.gastro.2013.01.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
55 Bielen R, Koc ÖM, Busschots D, Robaeys G, Aertgeerts B, Vaes B, Mamouris P, Mathei C, Goderis G, Nevens F. Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based study. BMJ Open 2019;9:e026464. [PMID: 31072855 DOI: 10.1136/bmjopen-2018-026464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Zuure FR, Urbanus AT, Langendam MW, Helsper CW, van den Berg CH, Davidovich U, Prins M. Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review. BMC Public Health 2014;14:66. [PMID: 24450797 DOI: 10.1186/1471-2458-14-66] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
57 Spradling PR, Xing J, Rupp LB, Moorman AC, Gordon SC, Lu M, Teshale EH, Boscarino JA, Schmidt MA, Daida YG, Holmberg SD; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017. J Clin Gastroenterol 2021;55:77-83. [PMID: 32250999 DOI: 10.1097/MCG.0000000000001344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
58 Kileng H, Gutteberg T, Goll R, Paulssen EJ. Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study. BMC Infect Dis 2019;19:189. [PMID: 30808290 DOI: 10.1186/s12879-019-3832-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Lu M, Zhou Y, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Boscarino JA, Daida YG, Schmidt MA, Li J, Rupp LB, Trudeau S, Gordon SC; Chronic Hepatitis Cohort Study Investigators. Trends in Diagnosed Chronic Hepatitis B in a US Health System Population, 2006-2015. Open Forum Infect Dis 2019;6:ofz286. [PMID: 31341929 DOI: 10.1093/ofid/ofz286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Lushniak BD. Surgeon general's perspectives. Public Health Rep 2014;129:220-1. [PMID: 24790250 DOI: 10.1177/003335491412900302] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Mahajan R, Moorman AC, Liu SJ, Rupp L, Klevens RM; Chronic Hepatitis Cohort Study (CHeCS) investigators*. Use of the International Classification of Diseases, 9th revision, coding in identifying chronic hepatitis B virus infection in health system data: implications for national surveillance. J Am Med Inform Assoc 2013;20:441-5. [PMID: 23462875 DOI: 10.1136/amiajnl-2012-001558] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
62 Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, Poropat G, Djurisic S, Weiss KH, Bjelakovic M, Bjelakovic G, Klingenberg SL, Liu JP, Nikolova D, Koretz RL, Gluud C. Direct-acting antivirals for chronic hepatitis C. Cochrane Database Syst Rev 2017;6:CD012143. [PMID: 28585310 DOI: 10.1002/14651858.CD012143.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
63 Serper M, Choi G, Forde KA, Kaplan DE. Care delivery and outcomes among U.S. veterans with hepatitis B: A national cohort study. Hepatology. 2015;Epub ahead of print. [PMID: 26561023 DOI: 10.1002/hep.28340] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
64 Roberts H, Boktor SW, Waller K, Daar ZS, Boscarino JA, Dubin PH, Suryaprasad A, Moorman AC. Underreporting of Hepatitis B and C virus infections - Pennsylvania, 2001-2015. PLoS One 2019;14:e0217455. [PMID: 31170165 DOI: 10.1371/journal.pone.0217455] [Reference Citation Analysis]
65 Al Humayed SM, Mahfouz AA, Awadalla NJ, Alsabaani AA. Hepatitis C Virus Infection at Primary Healthcare Level in Abha City, Southwestern Saudi Arabia: Is Type 2 Diabetes Mellitus an Associated Factor? Int J Environ Res Public Health 2018;15:E2513. [PMID: 30423991 DOI: 10.3390/ijerph15112513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
66 Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, Poropat G, Djurisic S, Weiss KH, Bjelakovic M, Bjelakovic G, Klingenberg SL, Liu JP, Nikolova D, Koretz RL, Gluud C. Direct-acting antivirals for chronic hepatitis C. Cochrane Database Syst Rev 2017;9:CD012143. [PMID: 28922704 DOI: 10.1002/14651858.CD012143.pub3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
67 Smith BD, Yartel AK, Krauskopf K, Massoud OI, Brown KA, Fallon MB, Rein DB. Hepatitis C virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: cross-sectional analysis of a multisite retrospective cohort study. Clin Infect Dis 2015;60:1145-52. [PMID: 25595745 DOI: 10.1093/cid/civ002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
68 Naidjate SS, Zullo AR, Dapaah-Afriyie R, Hersey ML, Marshall BDL, Winkler RM, Berard-Collins C. Comparative effectiveness of pharmacist care delivery models for hepatitis C clinics. Am J Health Syst Pharm 2019;76:646-53. [PMID: 30873537 DOI: 10.1093/ajhp/zxz034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Mahale P, Engels EA, Koshiol J. Hepatitis B virus infection and the risk of cancer in the elderly US population. Int J Cancer 2018;144:431-9. [DOI: 10.1002/ijc.31643] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
70 Yartel AK, Rein DB, Brown KA, Krauskopf K, Massoud OI, Jordan C, Kil N, Federman AD, Nerenz DR, Brady JE, Kruger DL, Smith BD. Hepatitis C virus testing for case identification in persons born during 1945-1965: Results from three randomized controlled trials. Hepatology 2018;67:524-33. [PMID: 28941361 DOI: 10.1002/hep.29548] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
71 Mitruka K, Pezzi C, Baack B, Burke H, Cochran J, Matheson J, Urban K, Ramos M, Byrd K. Evaluation of Hepatitis B Virus Screening, Vaccination, and Linkage to Care Among Newly Arrived Refugees in Four States, 2009-2011. J Immigr Minor Health 2019;21:39-46. [PMID: 29417356 DOI: 10.1007/s10903-018-0705-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
72 Holmberg SD, Spradling PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med. 2013;368:1859-1861. [PMID: 23675657 DOI: 10.1056/nejmp1302973] [Cited by in Crossref: 239] [Cited by in F6Publishing: 138] [Article Influence: 26.6] [Reference Citation Analysis]
73 Kangas-Dick A, Gall V, Hilden P, Turner A, Greenbaum A, Sesti J, Paul S, Carpizo D, Kennedy T, Sadaria Grandhi M, Alexander HR, Wang S, Geffner S, August D, Langan RC. Disparities in utilization of services for racial and ethnic minorities with hepatocellular carcinoma associated with hepatitis C. Surgery 2020;168:49-55. [PMID: 32414566 DOI: 10.1016/j.surg.2020.03.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Lu M, Chacra W, Rabin D, Rupp LB, Trudeau S, Li J, Gordon SC. Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records. Clin Epidemiol 2017;9:369-76. [PMID: 28744162 DOI: 10.2147/CLEP.S136134] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
75 Moorman AC, Gordon SC, Rupp LB, Spradling PR, Teshale EH, Lu M, Nerenz DR, Nakasato CC, Boscarino JA, Henkle EM. Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study. Clin Infect Dis. 2013;56:40-50. [PMID: 22990852 DOI: 10.1093/cid/cis815] [Cited by in Crossref: 120] [Cited by in F6Publishing: 118] [Article Influence: 12.0] [Reference Citation Analysis]
76 Smith BD, Yartel AK. Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels. Am J Prev Med 2014;47:233-41. [PMID: 25145616 DOI: 10.1016/j.amepre.2014.05.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
77 Leidner AJ, Chesson HW, Xu F, Ward JW, Spradling PR, Holmberg SD. Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease. Hepatology. 2015;61:1860-1869. [PMID: 25677072 DOI: 10.1002/hep.27736] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 11.9] [Reference Citation Analysis]
78 Tien A, Sahota A, Yang SJ, Balbuena R, Chang M, Lim C, Fong TL. Prevalence and Characteristics of Chronic Hepatitis C Among Asian Americans Are Distinct From Other Ethnic Groups. J Clin Gastroenterol 2021;55:884-90. [PMID: 33074947 DOI: 10.1097/MCG.0000000000001447] [Reference Citation Analysis]
79 Roberts H, Kruszon-Moran D, Ly KN, Hughes E, Iqbal K, Jiles RB, Holmberg SD. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012. Hepatology. 2016;63:388-397. [PMID: 26251317 DOI: 10.1002/hep.28109] [Cited by in Crossref: 132] [Cited by in F6Publishing: 115] [Article Influence: 18.9] [Reference Citation Analysis]
80 Kruger DL, Rein DB, Kil N, Jordan C, Brown KA, Yartel A, Smith BD. Implementation of Birth-Cohort Testing for Hepatitis C Virus. Health Promot Pract 2017;18:283-9. [PMID: 27496859 DOI: 10.1177/1524839916661495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
81 Barbosa C, Fraser H, Hoerger TJ, Leib A, Havens JR, Young A, Kral A, Page K, Evans J, Zibbell J, Hariri S, Vellozzi C, Nerlander L, Ward JW, Vickerman P. Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs. Addiction 2019;114:2267-78. [PMID: 31307116 DOI: 10.1111/add.14731] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
82 Gardona RGB, Barbosa DA, Ferraz MLG. Screening for hepatitis C in urgent and emergency units: a systematic review. Rev Esc Enferm USP 2020;54:e03611. [PMID: 32901660 DOI: 10.1590/S1980-220X20180450-03611] [Reference Citation Analysis]
83 Daida YG, Boscarino JA, Moorman AC, Lu M, Rupp LB, Gordon SC, Teshale EH, Schmidt MA, Spradling PR; Chronic Hepatitis Cohort Study Investigators. Mental and physical health status among chronic hepatitis B patients. Qual Life Res 2020;29:1567-77. [PMID: 31938963 DOI: 10.1007/s11136-020-02416-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Bixler D, Zhong Y, Ly KN, Moorman AC, Spradling PR, Teshale EH, Rupp LB, Gordon SC, Boscarino JA, Schmidt MA, Daida YG, Holmberg SD, Holmberg SD, Teshale EH, Spradling PR, Moorman AC, Xing J, Zhong Y, Gordon SC, Nerenz DR, Lu M, Lamerato L, Li J, Rupp LB, Akkerman N, Zhang T, Trudeau S, Zhou Y, Wu K, Boscarino JA, Daar ZS, Smith RE, Daida YG, Trinacty CM, Lai JW, Wong CP, Schmidt MA, Donald JL; CHeCS Investigators. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS). Clinical Infectious Diseases 2019;68:956-63. [DOI: 10.1093/cid/ciy598] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
85 Brady JE, Liffmann DK, Yartel A, Kil N, Federman AD, Kannry J, Jordan C, Massoud OI, Nerenz DR, Brown KA, Smith BD, Vellozzi C, Rein DB. Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study. Hepatology 2017;65:44-53. [PMID: 27770543 DOI: 10.1002/hep.28880] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
86 Plant A, Snow EG, Montoya JA, Young S, Javanbakht M, Klausner JD. Test4HepC: Promoting Hepatitis C Testing to Baby Boomers Using Social Media. Health Promot Pract 2020;21:780-90. [PMID: 30854905 DOI: 10.1177/1524839919833987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Ditah I, Ditah F, Devaki P, Ewelukwa O, Ditah C, Njei B, Luma HN, Charlton M. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. J Hepatol. 2014;60:691-698. [PMID: 24291324 DOI: 10.1016/j.jhep.2013.11.014] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 11.8] [Reference Citation Analysis]
88 Spradling PR, Xing J, Rupp LB, Moorman AC, Gordon SC, Teshale ET, Lu M, Boscarino JA, Schmidt MA, Trinacty CM, Holmberg SD; Chronic Hepatitis Cohort Study Investigators. Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013. Aliment Pharmacol Ther. 2016;44:1080-1089. [PMID: 27640985 DOI: 10.1111/apt.13802] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
89 Chak EW, Sarkar S, Bowlus C. Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis. Dig Dis Sci 2016;61:2776-83. [PMID: 27234269 DOI: 10.1007/s10620-016-4205-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
90 Lohia P, Jinjuvadia R, May E. Profound jaundice in a patient with acute hepatitis C. BMJ Case Rep 2013;2013:bcr2013200233. [PMID: 24031074 DOI: 10.1136/bcr-2013-200233] [Reference Citation Analysis]
91 Southern WN, Norton B, Steinman M, DeLuca J, Drainoni ML, Smith BD, Litwin AH. A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study. BMC Infect Dis 2015;15:553. [PMID: 26626449 DOI: 10.1186/s12879-015-1283-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
92 Mukhtar NA, Toy BC, Burman BE, Yu A, Chen AH, Berman P, Nguyen T, Chan D, Hammer H, McCulloch CE, Khalili M. Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data. J Gen Intern Med 2015;30:68-74. [PMID: 25324148 DOI: 10.1007/s11606-014-3057-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
93 Lu M, Rupp LB, Moorman AC, Li J, Zhang T, Lamerato LE, Holmberg SD, Spradling PR, Teshale EH, Vijayadeva V, Boscarino JA, Schmidt MA, Nerenz DR, Gordon SC. Comparative effectiveness research of chronic hepatitis B and C cohort study (CHeCS): improving data collection and cohort identification. Dig Dis Sci 2014;59:3053-61. [PMID: 25030940 DOI: 10.1007/s10620-014-3272-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
94 Whitehead NE, Hearn LE, Marsiske M, Kahn MR, Latimer WW. Awareness of biologically confirmed HCV among a community residing sample of drug users in Baltimore City. J Community Health 2014;39:487-93. [PMID: 24173529 DOI: 10.1007/s10900-013-9782-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
95 Byrne DD, Newcomb CW, Carbonari DM, Nezamzadeh MS, Leidl KB, Herlim M, Yang YX, Hennessy S, Kostman JR, Leonard MB, Localio R, Lo Re V 3rd. Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007. Ann Epidemiol 2014;24:418-23. [PMID: 24703196 DOI: 10.1016/j.annepidem.2014.02.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
96 Spradling PR, Xing J, Rupp LB, Moorman AC, Gordon SC, Lu M, Teshale EH, Boscarino JA, Schmidt MA, Daida YG, Holmberg SD; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015. J Clin Gastroenterol 2018;52:641-7. [PMID: 28590325 DOI: 10.1097/MCG.0000000000000857] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
97 Hochstatter KR, Stockman LJ, Holzmacher R, Greer J, Seal DW, Taylor QA, Gill EK, Westergaard RP. The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care. Health Justice 2017;5:10. [PMID: 29086078 DOI: 10.1186/s40352-017-0055-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
98 Heil J, Hoebe CJPA, Cals JWL, Ter Waarbeek HLG, van Loo IHM, Dukers-Muijrers NHTM. Detecting Hepatitis B and C by Combined Public Health and Primary Care Birth Cohort Testing. Ann Fam Med 2018;16:21-7. [PMID: 29311171 DOI: 10.1370/afm.2166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
99 Moorman AC, Rupp LB, Gordon SC, Zhong Y, Xing J, Lu M, Boscarino JA, Schmidt MA, Daida YG, Teshale EH, Spradling PR, Holmberg SD; CHeCS Investigators. Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings. Infect Dis Clin North Am. 2018;32:253-268. [PMID: 29778254 DOI: 10.1016/j.idc.2018.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
100 Geboy AG, Nichols WL, Fernandez SJ, Desale S, Basch P, Fishbein DA. Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system. PLoS One 2019;14:e0216459. [PMID: 31120906 DOI: 10.1371/journal.pone.0216459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
101 Calner P, Sperring H, Ruiz-Mercado G, Miller NS, Andry C, Battisti L, Scrudder K, Shea F, Chan A, Schechter-Perkins EM. HCV screening, linkage to care, and treatment patterns at different sites across one academic medical center. PLoS One 2019;14:e0218388. [PMID: 31291275 DOI: 10.1371/journal.pone.0218388] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
102 Ramirez G, Cabral R, Patterson M, Schoenbachler BT, Bedell D, Smith BD, Vellozzi C, Beckett GA. Early Identification and Linkage to Care for People with Chronic HBV and HCV Infection: The HepTLC Initiative. Public Health Rep 2016;131 Suppl 2:5-11. [PMID: 27168655 DOI: 10.1177/00333549161310S202] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
103 Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol. 2014;109:542-553. [PMID: 24513805 DOI: 10.1038/ajg.2014.11] [Cited by in Crossref: 269] [Cited by in F6Publishing: 253] [Article Influence: 33.6] [Reference Citation Analysis]
104 Houri I, Horowitz N, Katchman H, Weksler Y, Miller O, Deutsch L, Shibolet O. Emergency department targeted screening for hepatitis C does not improve linkage to care. World J Gastroenterol 2020; 26(32): 4878-4888 [PMID: 32921964 DOI: 10.3748/wjg.v26.i32.4878] [Reference Citation Analysis]
105 Golden MR, Duchin J, Chew LD, Huntington JH, Sugg N, Jackson S, Lane A, Pecha M, Barash E, Scott J. Impact of an Electronic Medical Record-Based System to Promote Human Immunodeficiency Virus/Hepatitis C Virus Screening in Public Hospital Primary Care Clinics. Open Forum Infect Dis 2017;4:ofx075. [PMID: 28584856 DOI: 10.1093/ofid/ofx075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
106 McEwan P, Ward T, Yuan Y, Kim R, L’italien G. The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States. Hepatology. 2013;58:54-64. [PMID: 23389841 DOI: 10.1002/hep.26304] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 6.8] [Reference Citation Analysis]
107 Ditah I, Al Bawardy B, Gonzalez HC, Saberi B, Ditah C, Kamath PS, Charlton M. Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study. Am J Gastroenterol. 2015;110:1126-1133. [PMID: 25756239 DOI: 10.1038/ajg.2015.31] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
108 Litaker JR, Tamez N, Lopez Bray C, Allison RD, Durkalski W, Taylor R. Hepatitis C Antibody Screening Among Baby Boomers by a Community-Based Health Insurance Company. Popul Health Manag 2021;24:492-5. [PMID: 33197366 DOI: 10.1089/pop.2020.0214] [Reference Citation Analysis]
109 Larney S, Zaller ND, Dumont DM, Willcock A, Degenhardt L. A systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations. Annals of Epidemiology 2016;26:570-578.e2. [DOI: 10.1016/j.annepidem.2016.06.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
110 Mena A, Moldes L, Meijide H, Cañizares A, Castro-Iglesias A, Delgado M, Pértega S, Pedreira J, Bou G, Poveda E. Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing. PLoS One 2014;9:e113062. [PMID: 25436642 DOI: 10.1371/journal.pone.0113062] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
111 Miller LS, Rollin F, Fluker SA, Lundberg KL, Park B, Quairoli K, Niyibizi NK, Spaulding AC. High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care Among Underserved African Americans, Atlanta, Georgia, 2012-2013. Public Health Rep 2016;131 Suppl 2:84-90. [PMID: 27168666 DOI: 10.1177/00333549161310S213] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
112 Ma GX, Zhang GY, Jung MY, Ma XS, Zhai S, Zhao M, Ma X, Lee S. HCV Screening Behaviors and Infection Status among Vietnamese Americans. Am J Health Behav 2015;39:640-51. [PMID: 26248174 DOI: 10.5993/AJHB.39.5.6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
113 Linas BP, Hu H, Barter DM, Horberg M. Hepatitis C screening trends in a large integrated health system. Am J Med 2014;127:398-405. [PMID: 24486288 DOI: 10.1016/j.amjmed.2014.01.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
114 Henkle E, Lu M, Rupp LB, Boscarino JA, Vijayadeva V, Schmidt MA, Gordon SC; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohort. Clin Infect Dis 2015;60:514-22. [PMID: 25371489 DOI: 10.1093/cid/ciu879] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
115 Bourgi K, Brar I, Baker-Genaw K. Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast Michigan. PLoS One 2016;11:e0161241. [PMID: 27525983 DOI: 10.1371/journal.pone.0161241] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
116 Ullo M, Sugalski G. Electronic health record triggered hepatitis C screening in the ED. The American Journal of Emergency Medicine 2019;37:1968-70. [DOI: 10.1016/j.ajem.2019.03.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
117 Galbraith JW, Franco RA, Donnelly JP, Rodgers JB, Morgan JM, Viles AF, Overton ET, Saag MS, Wang HE. Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. Hepatology. 2015;61:776-782. [PMID: 25179527 DOI: 10.1002/hep.27410] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 12.4] [Reference Citation Analysis]
118 Petrukhina NB, Zorina OA, Rabinovich IM, Shilov AM. [The epidemiological relationship of periodontitis, intestinal dysbiosis, atherogenic dyslipidemia and metabolic syndrome]. Stomatologiia (Mosk) 2015;94:16-9. [PMID: 26145470 DOI: 10.17116/stomat201594216-19] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
119 Rosenberg ES, Hall EW, Sullivan PS, Sanchez TH, Workowski KA, Ward JW, Holtzman D. Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010. Clin Infect Dis 2017;64:1573-81. [PMID: 28449115 DOI: 10.1093/cid/cix202] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
120 Malov VA, Ubeeva EA, Ubeeva IP, Nikolaev SM, Umbetova KT. [Treatment of chronic viral hepatitis C with direct acting antiviral agent: review]. Ter Arkh 2019;91:86-9. [PMID: 32598617 DOI: 10.26442/00403660.2019.11.000307] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
121 Smith BD, Beckett GA, Yartel A, Holtzman D, Patel N, Ward JW. Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008. Am J Public Health 2014;104:474-81. [PMID: 24432883 DOI: 10.2105/AJPH.2013.301549] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
122 Ali M, Nadeem M, Numan M, Khalil AT, Maqbool K, Yousaf MZ, Shinwari ZK, Idrees M. Thirty years of HIV in Pakistan: a systematic review of prevalence and current scenario. Future Virology 2017;12:609-23. [DOI: 10.2217/fvl-2017-0009] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
123 Sangaramoorthy M, Yang J, DeRouen MC, Ho C, Somsouk M, Tana MM, Thompson CA, Gibbons J, Gomez SL, Shariff-Marco S. Disparities in Hepatocellular Carcinoma Incidence in California: An Update. Cancer Epidemiol Biomarkers Prev 2020;29:79-87. [PMID: 31719066 DOI: 10.1158/1055-9965.EPI-19-0560] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
124 Mahajan R, Midha V, Goyal O, Mehta V, Narang V, Kaur K, Singh A, Singh D, Bhanot R, Sood A. Clinical profile of hepatitis C virus infection in a developing country: India. J Gastroenterol Hepatol 2018;33:926-33. [PMID: 28921677 DOI: 10.1111/jgh.13995] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
125 Pezzi C, Lee D, Kumar GS, Kawasaki B, Kennedy L, Aguirre J, Titus M, Ford R, Mamo B, Urban K, Hughes S, Payton C, Scott K, Montour J, Jentes ES. Health screenings administered during the domestic medical examination of refugees and other eligible immigrants in nine US states, 2014-2016: A cross-sectional analysis. PLoS Med 2020;17:e1003065. [PMID: 32231391 DOI: 10.1371/journal.pmed.1003065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Cloherty G, Talal A, Coller K, Steinhart C, Hackett J Jr, Dawson G, Rockstroh J, Feld J. Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection. J Clin Microbiol 2016;54:265-73. [PMID: 26659219 DOI: 10.1128/JCM.02407-15] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
127 Maier MM, Ross DB, Chartier M, Belperio PS, Backus LI. Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration. Am J Public Health 2016;106:353-8. [PMID: 26562129 DOI: 10.2105/AJPH.2015.302927] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
128 Auf R, Cano MÁ, Selim M, O'Connell D, Martin S, Ibañez GE. Hepatitis C Virus and Hispanic Criminal Justice Clients: A Missed Opportunity. J Immigr Minor Health 2020;22:701-7. [PMID: 31502109 DOI: 10.1007/s10903-019-00931-4] [Reference Citation Analysis]
129 Yan M, Ha J, Aguilar M, Bhuket T, Liu B, Gish RG, Cheung R, Wong RJ. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival. J Hepatol 2016;64:326-32. [PMID: 26386160 DOI: 10.1016/j.jhep.2015.09.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]